Seminars in Thrombosis and Hemostasis

Papers
(The TQCC of Seminars in Thrombosis and Hemostasis is 8. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2022-08-01 to 2026-08-01.)
ArticleCitations
98
63
Thrombotic Antiphospholipid Syndrome and Direct Oral Anticoagulants: Unmet Needs and Review of the Literature58
Drug–Drug Interactions in the Treatment of Cancer-Associated Venous Thromboembolism with Direct Oral Anticoagulants54
Redefining Fibrinolytic Insufficiency in Sepsis-Associated DIC44
Hemostatic Manifestations of Invasive Fungal Infections: A Comprehensive Review of Pathophysiological Mechanisms in Sepsis-Induced Hemostatic Disturbances, with a Focus on the Neonatal Population44
Thrombosis in Antiphospholipid Syndrome: Current Perspectives and Challenges in Laboratory Testing for Antiphospholipid Antibodies41
Role of Platelets in Rheumatic Chronic Autoimmune Inflammatory Diseases39
Fright of Long-Haul Flights: Focus on Travel-Associated Thrombosis37
Monitoring Hemostatic Function During Extracorporeal Membrane Oxygenation with Point-of-Care Viscoelastic Assays: A Narrative Review36
The Next, Next-Generation of Sequencing, Promising to Boost Research and Clinical Practice35
Too Old for PESI?: Risk Stratification of Octogenarians with Pulmonary Embolism in the Emergency Department34
Prevention of Venous Thromboembolism in Medical Patients with Thrombocytopenia or with Platelet Dysfunction: The Last 10 Years32
Resonant Acoustic Rheometry to Measure Coagulation Kinetics in Hemophilia A and Healthy Plasma: A Novel Viscoelastic Method29
Thrombin Generation Assays in Clinical Hemostasis: From Mechanistic Insights to Clinical Applications28
Application of ACR/EULAR Classification Criteria in Real Life: Thrombotic Patients Positive for Lupus Anticoagulant Only28
Platelet Function Testing: Update and Future Directions26
Gut Microbiota and Venous Thromboembolism: An Emerging Link26
Lupus Anticoagulant-hypoprothrombinemia Syndrome: A Review Enriched by a New Particular Patient26
Editorial Compilation—XIII25
Evolution of Clinical Trials in Anticoagulation for Sepsis: Bridging Past to Future25
Anticoagulation Management of Patients with Antiphospholipid Syndrome Undergoing Cardiopulmonary Bypass in Cardiac Surgery: Challenges and Current Strategies25
The History of Rare Bleeding Disorders24
How Do Laboratories Perform von Willebrand Disease Diagnostics and Classification of von Willebrand Disease Patients? Results from External Quality Data and an International Survey23
Autoantibodies in Autoimmune Coagulation Factor Deficiencies: A Review of Inhibitory and Clearance-Accelerating Mechanisms from Japanese Practice22
Anti-platelet Factor 4 Antibody-Mediated Disorders: An Updated Narrative Review22
22
Fifty Years of Fibrinogen Structure and Function21
Platelet Function: Acute versus Chronic Responses to Physical Exercise: A Review21
Gene Therapy for Hemophilia B: Achievements, Open Issues, and Perspectives21
Evolving Knowledge on Primary and Secondary Prevention of Venous Thromboembolism in Carriers of Hereditary Thrombophilia: A Narrative Review21
External Quality Assessment for Unfractionated Heparin Monitoring: An Update from Australasia/Asia-Pacific20
Modulating Immune Responses: The Double-Edged Sword of Platelet CD40L19
Bleeding in Patients with Renal Impairment: A Current Perspective19
Toward 50 Years of Seminars in Thrombosis and Hemostasis19
Patterns of Antiphospholipid Antibody Testing and Positivity in a Real-World Laboratory over Two Decades: The Role of IgM19
Magnetic Resonance Screening for Cerebral Venous Sinus Thrombosis during Treatment with Pegaspargase19
50 Years of Pediatric Hemostasis: Knowledge, Diagnosis, and Treatment19
Platelet Function in Patients with Disseminated Intravascular Coagulation: Potential Markers for Improving DIC Diagnosis?18
Platelet–Red Blood Cell Interactions in Thrombosis: Integrating Hemodynamic, Molecular, and Clinical Evidence–A Systematic Review17
Investigating a Signal of Acquired Hemophilia Associated with COVID-19 Vaccination: A Systematic Case Review17
Comprehensive Mendelian Randomization Analysis of Smoking and Its Effects on Venous Thromboembolism17
Celebrating 50 Years of Seminars in Thrombosis and Hemostasis—Part III16
Association between Severe Acute Respiratory Syndrome Coronavirus 2 Infection (Coronavirus Disease 2019) and Lupus Anticoagulant-Hypoprothrombinemia Syndrome: A Case Report and Literature Assessment16
Bernard–Soulier Syndrome: A Review of Epidemiology, Molecular Pathology, Clinical Features, Laboratory Diagnosis, and Therapeutic Management16
Large Language Models for Viscoelastic Tests: A Head-to-Head Evaluation of ChatGPT, Gemini, and DeepSeek for Thromboelastography and ROTEM Interpretation15
In Search of the Perfect Thrombosis and Bleeding-Associated Cancer Scale15
Use of Present-on-Admission Indicators to Improve Accuracy of Pulmonary Embolism Identification from Electronic Health Record Data15
Reply to the Comment: Research Design Concerns in a TriNetX Analysis of Venous Thromboembolism in Pediatric Cystic Fibrosis Patients15
15
Mendelian Randomization Provides No Evidence for the Bidirectional Relationship between Type 2 Diabetes and Venous Thromboembolism in East Asians and African Americans15
Automation in Platelet Function Testing: Current Challenges and Future Directions15
External Quality Assessment Data for Investigation of von Willebrand Disease: Focus on Relative Utility of Contemporary Functional von Willebrand Factor Assays. The United Kingdom National External Qu15
From Ink Pens to Computers: A Personal Look Back at Landmark Changes during 5 Decades as a Clinical Laboratory Scientist in U.S. Hemostasis Laboratories15
Machine Learning Prediction of Stress-Induced D-dimer Reactivity in Male Physicians with and without Burnout15
Laboratory Testing for the Evaluation of Phenotypic Activated Protein C Resistance15
A Brief History of Hemostasis and Thrombosis at the Mayo Clinic14
Emicizumab in Type 3 von Willebrand Disease: Report of a Case with an Alloantibody and Literature Review14
Platelet-Count-Guided Low Molecular Weight Heparin Management of Catheter-Related Thrombosis in a Large Cohort of Patients with Newly Diagnosed Acute Leukemia14
Neutrophil Extracellular Traps: At the Interface of Thrombosis and Comorbidities14
Seminars in Thrombosis and Hemostasis: 2024 Impact Factor, Most Highly Cited Papers, and Other Journal Metrics14
14
Heparin-Like Anticoagulant: First Case Described in a Metastatic Biliopancreatic Cancer14
2025 Eberhard F. Mammen Award Announcements–Part II: Young Investigator Awards14
Strength of Anticoagulation in Moderate to Severe COVID-19 Illness: In Medio Stat Virtus?14
Clinical, Laboratory, and Molecular Aspects of Factor V Deficiency13
Optimizing Venous Stenting: Consensus Recommendations for Enhanced Management of Lower Extremity Deep Vein Thrombosis13
Red Blood Cell Biomechanics and Cancer-Associated Thrombosis13
Comparative Study of Venous Thromboembolic Prophylaxis Strategies for Patients with Ischemic Stroke: A Systematic Review and Network Meta-Analysis of Randomized Controlled Trials13
Physical Activity in People with Hemophilia13
Venous Thromboembolism in Children: The Rivaroxaban Experience13
Gene Therapy in Hemophilia A: Achievements, Challenges, and Perspectives13
Lipopolysaccharide and Coagulation Factor XII: Biophysics of Contact Activation in Infection13
External Quality Assessment for Low Molecular Weight Heparin Monitoring in the Australasia/Asia-Pacific Region12
Dosing Intensity of Anticoagulants for the Prevention and Treatment of Venous Thromboembolism and the Prevention of Stroke in Atrial Fibrillation: Why is There a Difference?12
International Council for Standardization in Haematology Guidance for New Lot Verification of Coagulation Reagents, Calibrators, and Controls12
The Erythrocyte–ROS Axis in Thrombosis and Hemostasis12
Comparison of the Coagulation Profile Following Treatment of Major Surgical Haemorrhage with Fresh Frozen Plasma or Fibrinogen Concentrate12
Editorial Compilation—Part XVIII11
Past, Present, and Future Perspectives of Plasminogen Activator Inhibitor 1 (PAI-1)11
Hematohidrosis in 15th Century Renaissance Art and a Review of Modern Literature11
Comparison of Platelet Function Tests for Long-Term Cardiovascular Events after Percutaneous Coronary Interventions11
Emicizumab in Acquired Hemophilia A: A Real-World Case Series with Patient-Level Outcome Analysis11
Impact of Hematocrit on Coagulation Measured by Rotational Thromboelastometry in Healthy Subjects and Patients with Polycythemia11
Risk Factors for Left Ventricular Thrombus Formation in Patients with Dilated Cardiomyopathy11
Editorial Compilation XIV11
Bleeding Scoring Systems in Neonates: A Systematic Review11
100 Years of von Willebrand Disease: The Journey to Contemporary Diagnostic Pathways—An Illustrative Case-Based Narrative Review11
Pulmonary Embolism-Related Mortality in Femur Fracture Patients: A Recent Retrospective Epidemiological Analysis11
Acquired Hemostasis Disorders11
Decoding Clot Waveform Analysis: Toward Better Understanding and Harmonization11
Bridging the Gap in Laboratory Monitoring of Extended Half-Life Factor VIII and IX: Can Thrombin Generation Assays Overcome Assay Discrepancies?11
11
COVID-19 Vaccine-Associated Immune Thrombosis and Thrombocytopenia (VITT): Diagnostic Discrepancies and Global Implications11
Mortality from Pulmonary Embolism in Patients with Post-Coronavirus Disease Syndrome11
The Pathophysiological Role of Platelet-Derived Extracellular Vesicles11
A Historical Perspective on the Reversal of Anticoagulants11
Pleiotropic Effects of Heparin and its Monitoring in the Clinical Practice10
Platelet Physiology10
Cancer-Associated Thrombosis and Beyond: Biomarkers, Treatments, and Cancer-Hemostasis Interactions10
D-Dimer Reporting and Harmonization: Analysis of College of American Pathologists D-Dimer Proficiency Testing Program10
Clinical Features of Antiphospholipid Syndrome with Intracardiac Mass10
Do we Have the Gut to Beat Thrombosis?10
A Perspective on How Fibrinaloid Microclots and Platelet Pathology May be Applied in Clinical Investigations10
COVID-19 and Anticoagulant Use: Did the Pandemic Push DOACs Ahead of Warfarin?10
Evaluating Diagnostic Algorithms for Heparin-Induced Thrombocytopenia using Two Combined Automated Rapid Immunoassays10
Thrombin Generation Assays: What are the Current Clinical Applications?10
The Applicability of Thromboelastography in Acute Ischemic Stroke: A Literature Review10
Precision Medicine in Rare Bleeding Disorders9
9
Hemostasis Testing in the Emergency Department: A Narrative Review9
Use of Plasma-Derived FVII Concentrate in Surgical Patients with Factor VII Deficiency: A Case Series9
Heterogeneity Among Plasma-Derived von Willebrand Factor Concentrates: Implications for Comparative Effectiveness Analyses9
Emerging Use of Viscoelastography in Thrombosis and Hemostasis: A Challenge to Conventional Coagulation Tests? Part I: The Use of Thromboelastography and Thromboelastometry in the Assessment of Hemost9
Activated Partial Thromboplastin Time and Prothrombin Time Mixing Studies: Current State of the Art9
Diagnosis and Management of Recurrent Thrombosis and Pregnancy Loss in a Patient with Multilevel Thrombophilia9
Transitioning of Patients from Direct-Acting Oral Anticoagulant to Heparin: Impact on Laboratory Testing9
Current Diagnosis of von Willebrand Disease in Italy: 3 Years Following the Release of the International Guidelines9
National Early Warning Score-2 for Identification of Patients with Intermediate-High-Risk Pulmonary Embolism9
9
Safety and Efficacy of Therapeutic Anticoagulation with Subcutaneous Unfractionated Heparin in Patients with Renal Failure9
Von Willebrand Disease Type 2A: An Update9
NETosis in Acute Thrombotic Disorders9
Non-factor Therapies for Hemophilia: Achievements and Perspectives9
The Role of Platelets in Atherosclerosis: A Historical Review9
Dysregulation of the FVIII–VWF Axis in Early-Onset Ischemic Stroke8
Laboratory Testing for Fibrinogen Disorders: From Routine Investigations to Research Studies8
Discordant High Activated Partial Thromboplastin Time Relative to Anti-Xa Values in Hospitalized Patients is an Independent Risk Factor for Increased 30-day Mortality8
PFA-100 System: A New Method for Assessment of Platelet Dysfunction8
2022 Eberhard F. Mammen Award Announcements: Part II—Young Investigator Awards8
One Hundred Years of Congenital Fibrinogen Disorders8
Hemostatic Aspects of Interactions Between Anticancer Drugs and Oral Anticoagulants in Patients with Cancer-Associated Venous Thromboembolism8
Why Does Rivaroxaban Not Work in Severe Mitral Stenosis?8
Evolution of Antiphospholipid Syndrome8
Increased HDL-C Values and Mortality: Revolutionizing a Historical Paradigm?8
It Is Proposed That Cardiovascular Functions are Regulated by the Status of Ecto-phosphoproteins Orchestrated by Platelets8
Factor Replacement Treatment for Hemophilia A: Achievements and Perspectives8
0.12822914123535